J Lab Med Qual Assur.  2009 Jun;31(1):199-205.

Performance Evaluation of MassTrak LC/MS/MS Tacrolimus Kit

Affiliations
  • 1Department of Laboratory Medicine, Konkuk University College of Medicine, Seoul, Korea. doctory@paran.com

Abstract

BACKGROUND
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) are used increasingly for tacrolimus monitoring. However, there are still variability of results due to home-brew reagents, so which cannot be warrantable data. We evaluated the analytical performance and clinical usefulness of a newly introduced MassTrak LC/MS/MS Tacrolimus kit (Waters Corporation, USA).
METHODS
The performance of LC-MS/MS for determination of tacrolimus concentration were analyzed using patient samples and MassTrak LC/MS/MS Tacrolimus kit including calibrators, quality controls, internal standard, column and neat solution with respect to linearity, precision, lower limit of detection, lower limit of quantitation, sample carryover and comparison according to CLSI guidelines. The LC-MS/MS using home-brew reagents were performed for comparison test.
RESULTS
The LC-MS/MS using MassTrak LC/MS/MS Tacrolimus kit showed a good linearity (R2> or =0.997) and precision (CV< 8%). Assigned LLOD (0.4 ng/mL) and LLOQ (0.8 ng/mL) were validated and carryover was estimated 0.5%. The system correlated well with the LC-MS/MS using home-brew reagents (R> or =0.974).
CONCLUSIONS
LC-MS/MS using MassTrak LC/MS/MS Tacrolimus kit for determination of tacrolimus concentration showed good performance for linearity, precision, LLOD, LLOQ, carryover and comparison. Introduction of MassTrak LC/MS/MS Tacrolimus kit could be warranted results by manufacturer and useful for management of quality control.

Keyword

Tacrolimus; MassTrak; Tandem mass; LC-MS/MS

MeSH Terms

Humans
Indicators and Reagents
Limit of Detection
Mass Spectrometry
Quality Control
Tacrolimus
Indicators and Reagents
Tacrolimus
Full Text Links
  • JLMQA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr